Global Continuous Peripheral Nerve Block Catheter Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
Stimulating Catheter, Non-stimulating Catheter, and Over-the-needle Catheter.By Insertion Technique;
Nerve Stimulation, and Ultrasound.By Indication;
Trauma Cases, Upper Extremity Surgeries, Lower Extremity Surgeries, Pain Management, and Others.By End User;
Hospitals, and Ambulatory Surgical Centers.By Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Continuous Peripheral Nerve Block Catheter Market (USD Million), 2021 - 2031
In the year 2024, the Global Continuous Peripheral Nerve Block Catheter Market was valued at USD 2,005.04 million. The size of this market is expected to increase to USD 2,876.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.3%.
The Global Continuous Peripheral Nerve Block Catheter Market continues to expand rapidly, fueled by the increasing demand for precise, opioid-sparing postoperative pain management solutions. Continuous peripheral nerve block (CPNB) catheters are emerging as a preferred alternative to systemic analgesics, offering targeted delivery of local anesthetics that can reduce opioid consumption by up to 50%. Their role in facilitating faster recovery and minimizing drug-related complications is being widely acknowledged across surgical practices.
The market has seen over a 35% increase in adoption due to the rising volume of surgical procedures that benefit from regional anesthesia. CPNB catheters are especially valued in ambulatory and outpatient settings, where enhanced recovery protocols require efficient and continuous pain control. Their use significantly improves patient comfort, reduces hospital length of stay, and supports early ambulation after surgery.
Technological innovations have further strengthened the market’s growth trajectory. Features like echogenic catheter tips, anti-microbial coatings, and programmable infusion systems have boosted procedural safety and efficiency. These advancements are making CPNB systems easier to use for clinicians and more reliable for long-term pain management, reinforcing their importance in modern perioperative care. Support from clinical guidelines and healthcare policies favoring non-opioid alternatives is accelerating product penetration. As patient expectations rise and hospitals emphasize outcome-driven care, the widespread adoption of continuous peripheral nerve block catheters is expected to continue increasing steadily.
Global Continuous Peripheral Nerve Block Catheter Market Recent Developments
-
In July 2023, Solo-Dex, a U.S.-based medical technology company, entered into a master distribution agreement with Farouk, Maamoun Tamer & Co. and CH Trading Group LLC. This strategic collaboration is aimed at expanding the reach of Solo-Dex’s Fascile product line, which includes continuous peripheral nerve block catheters, into the Middle Eastern and North African markets. The partnership is expected to enhance regional access to advanced pain management solutions and drive adoption in key surgical and outpatient care settings. This move marks a significant step for Solo-Dex in scaling its international distribution network and aligning with experienced partners that bring established market presence and operational infrastructure. By leveraging the strengths of Farouk, Maamoun Tamer & Co. and CH Trading Group, Solo-Dex aims to accelerate commercial availability and strengthen its footprint in emerging healthcare markets.
-
In May 2023, Epimed International, Inc., a leading provider of nerve block solutions, announced the launch of its new product line, Epimed Essentials. This innovative lineup includes Epidural Nerve Block Needles and Epidural Needles, designed to enhance the precision and safety of regional anesthesia procedures. The introduction of Epimed Essentials reflects the company's commitment to expanding its portfolio of high-quality pain management tools. By offering specialized needle systems tailored for epidural procedures, Epimed aims to meet the growing clinical demand for reliable and effective nerve block products in both inpatient and outpatient settings.
Segment Analysis
In this report, the Global Continuous Peripheral Nerve Block Catheter Market has been segmented by Product Type, Insertion Technique, Indication, End User and Geography.
Global Continuous Peripheral Nerve Block Catheter Market, Segmentation by Product Type
The Global Continuous Peripheral Nerve Block Catheter Market has been segmented by Product Type into Stimulating Catheter, Non-stimulating Catheter and Over-the-needle Catheter.
Stimulating Catheter
Stimulating catheters are emerging as a critical component in the Global Continuous Peripheral Nerve Block Catheter Market due to their enhanced precision in targeting nerves. Equipped with electrical stimulation technology, these catheters assist clinicians in accurately positioning the catheter near the desired nerve, significantly improving the success rate of regional anesthesia procedures. Their ability to minimize complications and enhance pain management outcomes has driven their adoption across surgical specialties. Currently, stimulating catheters command around 35% of the total market share, reflecting their rising use in advanced medical settings.
Non-stimulating Catheter
Non-stimulating catheters continue to dominate the CPNB market due to their simplicity, cost-efficiency, and widespread usability. Unlike their stimulating counterparts, these catheters do not provide real-time nerve localization feedback but remain a reliable solution for routine procedures. Preferred especially in resource-limited environments, non-stimulating catheters maintain their position as the market leader, representing approximately 45% of global usage. Their durability and ease of application make them indispensable in day-to-day clinical workflows.
Over-the-needle Catheter
Over-the-needle catheters are gaining momentum in the continuous peripheral nerve block space for their ability to ensure more stable placement and minimize catheter migration. These catheters, which allow direct nerve access via a simplified insertion method, are increasingly being used in long-duration pain management cases. Though currently accounting for 20% of the market, over-the-needle catheters are poised for growth due to their clinical efficiency and rising demand in outpatient and ambulatory settings.
Global Continuous Peripheral Nerve Block Catheter Market, Segmentation by Insertion Technique
The Global Continuous Peripheral Nerve Block Catheter Market has been segmented by Insertion Technique into Nerve Stimulation and Ultrasound.
Nerve Stimulation
Nerve stimulation remains a reliable and widely used technique in the Global Continuous Peripheral Nerve Block Catheter Market. This method utilizes electrical stimulation to precisely locate the nerve, guiding catheter insertion for effective regional anesthesia. Its consistent performance and established clinical outcomes make it a preferred option in various healthcare environments, especially where ultrasound is not readily available. Currently, nerve stimulation holds a market share of approximately 40%, supported by its affordability and familiarity among anesthesiologists trained in traditional methods.
Ultrasound
Ultrasound-guided insertion has become the leading technique for placing continuous peripheral nerve block catheters, thanks to its superior visualization and safety profile. The method enables real-time imaging of nerve structures and adjacent anatomy, resulting in greater precision and fewer procedural risks. With growing availability of portable ultrasound equipment and improved practitioner training, ultrasound accounts for nearly 60% of global usage. Its popularity is further driven by increasing demands for minimally invasive and accurate regional anesthesia solutions.
Global Continuous Peripheral Nerve Block Catheter Market, Segmentation by Indication
The Global Continuous Peripheral Nerve Block Catheter Market has been segmented by Indication into Trauma Cases, Upper Extremity Surgeries, Lower Extremity Surgeries, Pain Management and Others.
Trauma Cases
In trauma cases, continuous peripheral nerve block catheters play a crucial role in delivering long-lasting and effective pain control. Their ability to reduce opioid dependency while ensuring sustained regional anesthesia makes them ideal for acute injury scenarios. Representing approximately 25% of the Global CPNB Catheter Market, their usage is rising, particularly in response to increasing trauma incidents from vehicular accidents and combat injuries. Hospitals and trauma centers are increasingly adopting this method for efficient and patient-centric pain relief.
Upper Extremity Surgeries
Continuous peripheral nerve block catheters are widely used in upper extremity surgeries, including shoulder arthroscopies, elbow repairs, and hand reconstructions. These catheters enable precise analgesia, which significantly enhances post-surgical recovery and reduces hospital stays. Holding about 30% of the market share, this segment benefits from the growth in outpatient procedures and advancements in orthopedic surgery techniques. The shift toward regional anesthesia protocols for upper limb surgeries continues to support this segment’s expansion.
Lower Extremity Surgeries
Lower extremity surgical procedures also represent a significant segment for the use of continuous nerve block catheters. Especially beneficial in knee and hip replacements, these catheters allow for targeted, extended pain management postoperatively. Approximately 20% of market share is attributed to this segment, which is projected to grow due to the increasing prevalence of osteoarthritis and the expanding elderly population undergoing joint replacements.
Pain Management and Others
Beyond surgery, pain management applications are gaining momentum in the global market. These catheters are used for chronic pain cases, including cancer-related pain, palliative care, and complex regional pain syndromes. Together with other minor indications, this category accounts for around 25% of the market. As healthcare systems prioritize opioid alternatives, the demand for long-term, catheter-based regional anesthesia is expected to continue rising steadily.
Global Continuous Peripheral Nerve Block Catheter Market, Segmentation by End User
The Global Continuous Peripheral Nerve Block Catheter Market has been segmented by End User into Hospitals and Ambulatory Surgical Centers.
Hospitals
Hospitals dominate the Continuous Peripheral Nerve Block Catheter Market by end user, accounting for nearly 70% of the global share. Their advanced infrastructure, skilled anesthesiology teams, and capacity for critical care make them the top choice for administering continuous nerve blocks in complex cases such as trauma, orthopedic surgeries, and chronic pain management. Hospitals also offer 24/7 monitoring, enhancing patient safety and outcomes. Their broad patient population and high surgical throughput reinforce their market leadership in this segment.
Ambulatory Surgical Centers (ASCs)
Ambulatory Surgical Centers are becoming an essential part of the market landscape, offering streamlined care for same-day procedures. With the global push toward cost-effective, minimally invasive surgeries, ASCs have grown in popularity for elective upper and lower limb procedures that utilize continuous peripheral nerve block catheters. Representing about 30% of market share, ASCs benefit from faster patient turnover and reduced hospital-acquired infection risks. As healthcare systems adapt to value-based care, ASCs are expected to see continued growth in catheter adoption.
Global Continuous Peripheral Nerve Block Catheter Market, Segmentation by Geography
In this report, the Global Continuous Peripheral Nerve Block Catheter Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Continuous Peripheral Nerve Block Catheter Market Share (%), by Geographical Region, 2024
North America
North America holds the leading position in the Global Continuous Peripheral Nerve Block Catheter Market, contributing approximately 40% of the total market share. This dominance is driven by the region’s advanced healthcare systems, widespread adoption of regional anesthesia techniques, and high volume of surgical interventions. The United States, in particular, plays a key role, supported by favorable reimbursement policies, skilled healthcare professionals, and the presence of leading catheter manufacturers.
Europe
Europe ranks second in the market, capturing nearly 25% of the global share. Nations such as Germany, the UK, and France lead the region’s adoption of continuous peripheral nerve block catheters. Increased emphasis on enhanced recovery protocols, rising elderly population, and the growing popularity of outpatient procedures have boosted market demand. Technological advancements and strong regulatory frameworks also contribute to consistent growth across the region.
Asia Pacific
The Asia Pacific region is experiencing rapid growth in the CPNB catheter market, currently accounting for about 20% of the global total. Driven by growing surgical volumes, rising awareness about pain management, and expanding healthcare investments, countries like China, India, Japan, and South Korea are accelerating adoption. As infrastructure improves and medical technology becomes more accessible, this region is expected to emerge as a major growth engine in the coming years.
Middle East & Africa and Latin America
Although currently accounting for a combined 15% of the market, Middle East & Africa and Latin America are steadily developing their presence. Growth in these regions is supported by increasing government investment in healthcare, urbanization, and greater demand for advanced surgical and pain management solutions. Emerging economies such as Brazil, Mexico, Saudi Arabia, and South Africa are focusing on improving access to anesthesia technologies to enhance patient outcomes.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Continuous Peripheral Nerve Block Catheter Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers:
- Aging population demand surge
- Technological advancements in catheters
- Increasing surgical procedures requiring blocks
- Growing prevalence of chronic diseases
- Rising awareness about pain management: The global continuous peripheral nerve block catheter market is experiencing significant growth, primarily driven by rising awareness about effective pain management techniques. With an increasing emphasis on patient comfort and satisfaction, healthcare providers are actively seeking innovative solutions to manage post-operative pain. Continuous peripheral nerve block catheters offer a promising alternative to traditional pain management methods such as opioids, which are associated with various side effects and risks of addiction. These catheters provide continuous infusion of local anesthetics directly to the nerves, resulting in targeted pain relief and reduced systemic side effects. As awareness about the benefits of these catheters grows among healthcare professionals and patients alike, the demand for such advanced pain management solutions is expected to continue rising.
Advancements in technology and medical device design are further fueling the expansion of the continuous peripheral nerve block catheter market. Manufacturers are investing in research and development to enhance the safety, efficacy, and usability of these catheters, making them increasingly attractive options for pain management across a wide range of surgical procedures. Additionally, the growing adoption of minimally invasive techniques in healthcare settings is driving the demand for catheters that can provide precise and long-lasting pain relief with minimal disruption to patients' recovery processes. As a result, the global continuous peripheral nerve block catheter market is poised for robust growth in the coming years, supported by both evolving healthcare needs and technological innovations.
Restraints:
- Limited accessibility in remote areas
- Concerns regarding catheter-associated infections
- Stringent regulatory approvals
- High costs associated with procedures
- Risk of nerve damage: The global continuous peripheral nerve block catheter market has witnessed significant growth in recent years, driven by factors such as the rising incidence of chronic pain conditions, increasing number of surgical procedures, and advancements in healthcare infrastructure. Continuous peripheral nerve block catheters are increasingly being adopted as they offer several advantages over traditional methods of pain management, including improved pain control, reduced opioid consumption, faster recovery times, and enhanced patient satisfaction. These catheters deliver local anesthetics directly to the nerves, providing targeted pain relief for an extended period, making them particularly beneficial for postoperative pain management and chronic pain conditions.
Despite their benefits, the use of continuous peripheral nerve block catheters is not without risks. One of the primary concerns is the potential for nerve damage associated with the insertion and placement of the catheter. Improper placement or accidental puncture of nerves can lead to temporary or permanent nerve injury, resulting in sensory or motor deficits, neuropathic pain, or other complications. Healthcare providers must undergo specialized training to accurately place these catheters and minimize the risk of nerve damage. Additionally, stringent protocols and guidelines are essential to ensure the safe and effective use of continuous peripheral nerve block catheters, including proper patient selection, monitoring, and management of complications.
Opportunities:
- Expansion in emerging markets
- Development of novel catheter designs
- Collaborations for research and development
- Focus on outpatient pain managemen
- Integration of telemedicine for consultations:
The integration of telemedicine for consultations has significantly impacted the global continuous peripheral nerve block catheter market. Telemedicine offers a convenient and efficient way for healthcare professionals to remotely monitor patients, provide consultations, and adjust treatment plans as needed. This integration has expanded access to specialized care, particularly in areas where access to healthcare services is limited. Patients can now receive expert advice and guidance from the comfort of their homes, reducing the need for frequent hospital visits and improving overall patient satisfaction.
The adoption of telemedicine has also streamlined the management of continuous peripheral nerve block catheters. Healthcare providers can remotely monitor catheter placement, assess patient response to treatment, and address any complications in real-time. This real-time monitoring not only enhances patient safety but also optimizes the utilization of healthcare resources. Additionally, telemedicine facilitates better communication and collaboration among healthcare teams, leading to more coordinated and personalized patient care. As telemedicine continues to evolve and become more widespread, it is expected to further drive growth in the continuous peripheral nerve block catheter market by improving patient outcomes and enhancing healthcare delivery efficiency.
Competitive Landscape Analysis
Key players in Global Continuous Peripheral Nerve Block Catheter Market include:
- Teleflex Incorporated
- B. Braun Melsungen AG
- Halyard Health, Inc
- Pajunk GmbH
- Epimed International Inc
- Becton, Dickinson and Company
- Kimberly-Clark Corporation
- Smiths Medical
- Ambu A/S
- Summit Medical Products, Inc
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Insertion Technique
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Continuous Peripheral Nerve Block Catheter Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging population demand surge
- Technological advancements in catheters
- Increasing surgical procedures requiring blocks
- Growing prevalence of chronic diseases
- Rising awareness about pain management
- Restraints
- Limited accessibility in remote areas
- Concerns regarding catheter-associated infections
- Stringent regulatory approvals
- High costs associated with procedures
- Risk of nerve damage
- Opportunities
- Expansion in emerging markets
- Development of novel catheter designs
- Collaborations for research and development
- Focus on outpatient pain managemen
- Integration of telemedicine for consultations
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Continuous Peripheral Nerve Block Catheter Market, By Product Type, 2021 -2031 (USD Million)
- Stimulating Catheter
- Non-stimulating Catheter
- Over-the-needle Catheter
- Global Continuous Peripheral Nerve Block Catheter Market, By Insertion Technique, 2021 -2031 (USD Million)
- Nerve Stimulation
- Ultrasound
- Global Continuous Peripheral Nerve Block Catheter Market, By Indication, 2021 -2031 (USD Million)
- Trauma Cases
- Upper Extremity Surgeries
- Lower Extremity Surgeries
- Pain Management
- Others
- Global Continuous Peripheral Nerve Block Catheter Market, By End User, 2021 -2031 (USD Million)
- Hospitals
- Ambulatory Surgical Centers
- Global Continuous Peripheral Nerve Block Catheter Market, By Geography, 2021 -2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Continuous Peripheral Nerve Block Catheter Market, By Product Type, 2021 -2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Teleflex Incorporated
- B. Braun Melsungen AG
- Halyard Health, Inc
- Pajunk GmbH
- Epimed International Inc
- Becton, Dickinson and Company
- Kimberly-Clark Corporation
- Smiths Medical
- Ambu A/S
- Summit Medical Products, Inc
- Company Profiles
- Analyst Views
- Future Outlook of the Market